Capital Impact Advisors, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q2 2020$2,154,000
+47.2%
12,6790.0%0.72%
+17.1%
Q1 2020$1,463,000
-32.5%
12,679
-68.7%
0.61%
-34.3%
Q4 2017$2,166,000
-1.7%
40,4950.0%0.94%
-5.0%
Q3 2017$2,203,000
+50.2%
40,495
+42.8%
0.98%
+47.3%
Q2 2017$1,467,000
-27.7%
28,351
-12.2%
0.67%
-17.3%
Q1 2017$2,029,000
+78.0%
32,284
-9.0%
0.81%
+50.5%
Q4 2014$1,140,000
-13.6%
35,4890.0%0.54%
+26750.0%
Q3 2014$1,319,000
-2.8%
35,4890.0%0.00%
-99.8%
Q2 2014$1,357,00035,4891.02%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 50,060,240$5,775,950,00035.57%
Lagoda Investment Management, L.P. 72,969$8,419,0009.97%
Avidity Partners Management LP 580,000$66,920,0009.25%
Arabesque Asset Management Ltd 14,807$1,708,0003.53%
Boxer Capital, LLC 400,000$46,152,0003.15%
Woodline Partners LP 364,333$42,037,0003.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,900$6,557,0002.99%
SECTORAL ASSET MANAGEMENT INC 107,000$12,346,0002.37%
Capital International, Inc./CA/ 1,197,659$138,186,0002.33%
Bain Capital Public Equity Management II, LLC 169,641$19,573,0002.29%
View complete list of SEATTLE GENETICS INC shareholders